Chelsea FC Women is to launch a fertility fund giving players access to assessments, treatments, counselling and workshops.

The initiative is part of a new partnership with London fertility clinic Fertility Plus, which has been named the club’s official fertility partner.

Chelsea said the fund will be available to every player in its women’s team, with support tailored to individual needs.

Giulia Mazzia, commercial director for Chelsea FC Women, said: “At Chelsea FC Women we are never done pushing for progress for our players and our community.

“This first-of-its-kind partnership with Fertility Plus will open up the conversation about fertility, help to raise awareness for our incredible fanbase and beyond, and give practical support to our players off the field as well as on it.”

Support through Fertility Plus will include fertility assessments and treatments, as well as counselling and workshops.

The partnership will also provide evidence-based information about reproductive health and address misconceptions around fertility.

Chelsea cited previous research on fertility knowledge which found that 41 per cent of respondents actively trying to conceive did not know when their fertile window was.

The club and Fertility Plus plan to provide educational content, resources comparing fertility myths with medical evidence and insights from Chelsea FC Women ambassadors.

Dr Amit Shah and Dr Anil Gudi, co-founders of Fertility Plus, said: “Elite sport asks a lot of women during the very years when fertility matters most, yet it’s a conversation the game has rarely had.

“Partnering with Chelsea FC Women allows us to help change that by giving players, staff and supporters access to trusted fertility expertise and compassionate, consultant-led care.

“We’re proud to work alongside a club that’s setting a new standard for supporting women’s health, both on and off the pitch.

Climbing during the third trimester was not linked to higher rates of self-reported pregnancy complications in a global study.

The findings provide direct evidence on an activity pregnant women have traditionally been advised to avoid because of concerns about falls.

Researchers surveyed 692 people about climbing during pregnancy, falls, maternal and baby health outcomes and their return to the activity after giving birth.

The study recorded almost 64,000 hours of climbing among participants.

During that time, participants reported 155 “hard falls”, defined as falls or catches forceful enough to be remembered or cause concern.

The rate of adverse clinical events, meaning negative medical outcomes affecting the pregnancy or baby, was 0.03 per 1,000 hours of climbing exposure. All babies in the study were born live.

Researchers found no significant difference in pregnancy or foetal health outcomes between participants who stopped climbing at or before 27 weeks and those who continued beyond that point.

The findings suggest continuing the activity into the third trimester was not associated with increased self-reported complications among those surveyed.

The survey also found 96 per cent of participants said that, despite concerns about climbing while pregnant, they felt “happy” or “very happy” that they had continued.

Margie Davenport, professor in the Faculty of Kinesiology, Sport, and Recreation and lead author of the study, said the preliminary findings challenge an assumption about maternal exercise that had been based on opinion rather than research.

She said: “For decades we have restricted pregnant women from activities like climbing due to concern for their health and the health of the baby, but our evidence suggests it’s beneficial for both mental and physical health.”

Higher coffee consumption has been linked to lower body fat, greater muscle mass and differing sex hormone patterns in men and women in a Finnish study.

Researchers found people who drank more coffee had lower levels of total and visceral fat, the fat stored around internal organs, as well as greater skeletal muscle mass.

These associations were seen even though participants had a similar body mass index (BMI), a measure of weight relative to height.

The University of Oulu study analysed data from 2,264 people aged 46 who were part of the Northern Finland Birth Cohort 1966, looking at habitual consumption alongside circulating metabolites, cardiometabolic risk markers and sex hormones.

In both men and women, higher consumption was correlated with lower circulating levels of branched-chain amino acids.

Persistently high levels of these molecules have previously been linked to insulin resistance, when the body responds less effectively to insulin, and a higher risk of type 2 diabetes.

The strongest differences between the sexes were seen in men. Higher consumption was linked to a more favourable glucose and insulin profile, higher total and bioavailable testosterone and increased levels of sex hormone-binding globulin (SHBG).

SHBG is a protein that carries sex hormones such as testosterone through the bloodstream and influences how much hormone is available for the body to use.

At the same time, free testosterone and the free androgen index were modestly lower in men.

Among women, hormone associations were more limited, mainly involving higher SHBG and lower measures of free androgens, a group of hormones that includes testosterone.

Luca Verroest, lead author of the study and doctoral researcher at the University of Oulu, said: “Coffee is consumed by millions of people every day, yet we still know surprisingly little about how it relates to our metabolism and hormones.

“What stood out in our findings was a distinct hormonal signature that didn’t disappear even after we took into account BMI and lifestyle factors, with several of these associations differing between men and women.”

The researchers said hormonal pathways could partly explain the relationship between consumption and metabolic health.

However, the research was observational, meaning it can identify associations but cannot establish that drinking coffee caused the biological differences seen among participants.

The study is particularly relevant in Finland, one of the world’s highest coffee-consuming countries, where annual consumption averages around 11.8 kilograms per person.

Researchers are now investigating whether coffee itself drives the biological changes and which compounds could be responsible, initially using animal models.

The longer-term aim is to move to human intervention studies, although the researchers said further research would be needed before the findings could be used to inform dietary recommendations.